InflaRx N.V.
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of…
Biotechnology
DE, Jena [HQ]
Government, Law & Regulation
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Awards
Obligations
InflaRx N.V. has no obligation with a government/award agency.
Latest Obligations
Contracts
$ 0.0
0.0 IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
YoY Trends
- No trends presentable at the moment.
Spending By Type
Awards
Obligations
Contracts
IDV Contracts
Grants
Loans
Direct
Other
InflaRx N.V. can't present spending by time.
Contract Analysis
Palmy tracks high-doted primary awards as well as their sub contracts on a regular basis.
This empowers you to dive deeper to unveil recent changes, risks and products/services InflaRx N.V.
offers.
There are no contract award details available for InflaRx N.V.